| (CNY) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.33B | -1.25% |
| Operating expense | — | — |
| Net income | 284.06M | 20.08% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 688513.SS returned -27.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -25.2% |
| 1 year | -27.2% |
| 5 years | +41.7% |
| All-time high | ¥65.53 (Aug 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 688513.SS would be worth today ›Yes. Chengdu Easton Biopharmaceuticals Co., Ltd. paid 1 dividend over the past 12 months. The most recent was ¥0.49 per share on Jun 2, 2026. The dividend yield is 1.02%.
Chengdu Easton Biopharmaceuticals Co., Ltd. is part of the Healthcare sector.
Chengdu Easton Biopharmaceuticals Co., Ltd. has a market cap of 7.57B CNY, based on the latest quote.